Ozempic (semaglutide) 1 mg, Novo Nordisk, Denmark Order Ozempic (semaglutide) 1 mg, Novo Nordisk, Denmark. International medicine delivery within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.

Indications for Ozempic®

Ozempic® is indicated for use in adult patients with type 2 diabetes mellitus along with diet and exercise to improve glycemic control as:

monotherapy;

combination therapy with other oral hypoglycemic drugs - metformin, metformin and sulfonylurea derivatives, metformin and/or thiazolidinedione, in patients who did not achieve adequate glycemic control during previous therapy;

combination therapy with insulin in patients who did not achieve adequate glycemic control during therapy Ozempic® and metformin.

Ozempic® is indicated to reduce the risk of major cardiovascular events* in patients with type 2 diabetes mellitus and high cardiovascular risk as an addition to standard treatment of cardiovascular diseases (based on an analysis of the time of onset of the first major cardiovascular event - see section "Pharmacological action", subsection "Evaluation of the effect on cardiovascular system").